Drug Interactions between agalsidase beta and Galafold
This report displays the potential drug interactions for the following 2 drugs:
- agalsidase beta
- Galafold (migalastat)
Interactions between your drugs
agalsidase beta migALAstat
Applies to: agalsidase beta and Galafold (migalastat)
Using agalsidase beta together with migALAstat is generally not recommended. Combining these medications may significantly increase the blood levels of agalsidase beta and increase its side effects. In addition, these medications are not intended to be used together for the treatment of Fabry disease. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
migALAstat food
Applies to: Galafold (migalastat)
Food reduces the absorption of migALAstat into the bloodstream, which may make the medication less effective in treating your condition. You should avoid eating for at least 2 hours before and 2 hours after taking migALAstat. Clear liquids may be consumed during this 4 hour period when you cannot eat.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Agents for fabry disease
Therapeutic duplication
The recommended maximum number of medicines in the 'agents for Fabry disease' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'agents for Fabry disease' category:
- agalsidase beta
- Galafold (migalastat)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.